Morphine Sulfate Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Morphine Sulfate Injection (injection) from Hikma Pharmaceuticals USA, Inc. with status Current. The shortage was first posted on Nov 3, 2017.
Shortage details
- Status
- Current
- Company
- Hikma Pharmaceuticals USA, Inc.
- Package NDC
- 0641-6020-10
- Dosage Form
- Injection
- Presentation
- Duramorph, Injection, .5 mg/1 mL (NDC 0641-6020-10)
- Initial Posting
- Nov 3, 2017